Private Trust Company’s Insmed INSM Stock Holding History

Private Trust Company’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$960	Sell	9 -41	-82%	-$4.96K	﹤0.01%	2593
2026 Q1	$8.18K	Hold	50	–	–	﹤0.01%	2043
2025 Q4	$8.7K	Sell	50 -23	-32%	-$4.2K	﹤0.01%	1990
2025 Q3	$10.5K	Sell	73 -56	-43%	-$6.86K	﹤0.01%	1890
2025 Q2	$13K	Sell	129 -93	-42%	-$7.11K	﹤0.01%	1724
2025 Q1	$16.9K	Buy	222 +38	+21%	+$2.91K	﹤0.01%	1622
2024 Q4	$12.7K	Sell	184 -34	-16%	-$2.45K	﹤0.01%	1664
2024 Q3	$15.9K	Buy	218 +107	+96%	+$7.9K	﹤0.01%	1552
2024 Q2	$7.44K	Buy	+111	New	+$4.3K	﹤0.01%	1785
2023 Q4	–	Sell	-115	Closed	-$2.9K	–	2369
2023 Q3	$2.9K	Hold	115	–	–	﹤0.01%	2051
2023 Q2	$2.43K	Hold	115	–	–	﹤0.01%	2075
2023 Q1	$1.96K	Hold	115	–	–	﹤0.01%	2083
2022 Q4	$2K	Buy	+115	New	+$2.22K	﹤0.01%	2021

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Private Trust Company's INSM Position: Q2 2026 in Review

Private Trust Company reduced its Insmed (INSM) stake by 82% in Q2 2026, selling an estimated $4.96K and leaving 9 shares worth $960. The position accounts for ﹤0.01% of the portfolio, ranked #2593.

Private Trust Company first reported a position in INSM in Q4 2022 and has held it in 13 quarters since. The position peaked at $16.9K in Q1 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Private Trust Company held 9 shares of Insmed worth $960 as of Q2 2026.
Private Trust Company sold 41 Insmed shares in Q2 2026, an estimated $4.96K.
Insmed made up ﹤0.01% of Private Trust Company's portfolio in Q2 2026, its #2593 holding.
Private Trust Company first reported a position in Insmed in Q4 2022 and has held it in 13 quarters since.
Private Trust Company's Insmed position peaked at $16.9K in Q1 2025.
667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.